vs
Opendoor Technologies Inc.（OPEN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Opendoor Technologies Inc.的季度营收约是Royalty Pharma plc的1.2倍（$736.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -148.9%，领先183.4%），Royalty Pharma plc同比增速更快（4.8% vs -32.1%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -21.1%）
Opendoor Technologies Inc.是一家主营住宅房地产买卖的线上企业，总部位于旧金山。平台可通过线上流程向房主提供房屋即时现金报价，收购房产后进行修缮再重新挂牌出售，同时还提供基于移动端应用的购房服务及配套融资方案，截至2021年11月业务覆盖美国44个区域市场。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
OPEN vs RPRX — 直观对比
营收规模更大
OPEN
是对方的1.2倍
$622.0M
营收增速更快
RPRX
高出36.9%
-32.1%
净利率更高
RPRX
高出183.4%
-148.9%
两年增速更快
RPRX
近两年复合增速
-21.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $736.0M | $622.0M |
| 净利润 | $-1.1B | $214.2M |
| 毛利率 | 7.7% | — |
| 营业利润率 | -20.4% | 62.4% |
| 净利率 | -148.9% | 34.4% |
| 营收同比 | -32.1% | 4.8% |
| 净利润同比 | -869.9% | 2.9% |
| 每股收益（稀释后） | $-1.42 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPENRPRX
| Q4 25 | $736.0M | $622.0M | ||
| Q3 25 | $915.0M | $609.3M | ||
| Q2 25 | $1.6B | $578.7M | ||
| Q1 25 | $1.2B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.4B | $564.7M | ||
| Q2 24 | $1.5B | $537.3M | ||
| Q1 24 | $1.2B | $568.0M |
净利润OPENRPRX
| Q4 25 | $-1.1B | $214.2M | ||
| Q3 25 | $-90.0M | $288.2M | ||
| Q2 25 | $-29.0M | $30.2M | ||
| Q1 25 | $-85.0M | $238.3M | ||
| Q4 24 | $-113.0M | $208.2M | ||
| Q3 24 | $-78.0M | $544.0M | ||
| Q2 24 | $-92.0M | $102.0M | ||
| Q1 24 | $-109.0M | $4.8M |
毛利率OPENRPRX
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 8.2% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.6% | — | ||
| Q2 24 | 8.5% | — | ||
| Q1 24 | 9.7% | — |
营业利润率OPENRPRX
| Q4 25 | -20.4% | 62.4% | ||
| Q3 25 | -7.4% | 70.1% | ||
| Q2 25 | -0.8% | 36.3% | ||
| Q1 25 | -4.9% | 94.0% | ||
| Q4 24 | -8.7% | 60.9% | ||
| Q3 24 | -4.9% | — | ||
| Q2 24 | -4.8% | 50.2% | ||
| Q1 24 | -7.4% | -13.0% |
净利率OPENRPRX
| Q4 25 | -148.9% | 34.4% | ||
| Q3 25 | -9.8% | 47.3% | ||
| Q2 25 | -1.9% | 5.2% | ||
| Q1 25 | -7.4% | 41.9% | ||
| Q4 24 | -10.4% | 35.1% | ||
| Q3 24 | -5.7% | 96.3% | ||
| Q2 24 | -6.1% | 19.0% | ||
| Q1 24 | -9.2% | 0.8% |
每股收益（稀释后）OPENRPRX
| Q4 25 | $-1.42 | $0.49 | ||
| Q3 25 | $-0.12 | $0.67 | ||
| Q2 25 | $-0.04 | $0.07 | ||
| Q1 25 | $-0.12 | $0.55 | ||
| Q4 24 | $-0.16 | $0.46 | ||
| Q3 24 | $-0.11 | $1.21 | ||
| Q2 24 | $-0.13 | $0.23 | ||
| Q1 24 | $-0.16 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $962.0M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.0B | $9.7B |
| 总资产 | $2.4B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资OPENRPRX
| Q4 25 | $962.0M | $618.7M | ||
| Q3 25 | $962.0M | $938.9M | ||
| Q2 25 | $789.0M | $631.9M | ||
| Q1 25 | $559.0M | $1.1B | ||
| Q4 24 | $679.0M | $929.0M | ||
| Q3 24 | $837.0M | $950.1M | ||
| Q2 24 | $809.0M | $1.8B | ||
| Q1 24 | $990.0M | $843.0M |
总债务OPENRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益OPENRPRX
| Q4 25 | $1.0B | $9.7B | ||
| Q3 25 | $811.0M | $9.6B | ||
| Q2 25 | $631.0M | $9.5B | ||
| Q1 25 | $645.0M | $9.8B | ||
| Q4 24 | $713.0M | $10.3B | ||
| Q3 24 | $801.0M | $10.3B | ||
| Q2 24 | $845.0M | $9.8B | ||
| Q1 24 | $899.0M | $9.9B |
总资产OPENRPRX
| Q4 25 | $2.4B | $19.6B | ||
| Q3 25 | $2.7B | $19.3B | ||
| Q2 25 | $2.9B | $18.3B | ||
| Q1 25 | $3.3B | $17.6B | ||
| Q4 24 | $3.1B | $18.2B | ||
| Q3 24 | $3.4B | $18.0B | ||
| Q2 24 | $3.4B | $17.7B | ||
| Q1 24 | $3.4B | $16.1B |
负债/权益比OPENRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $67.0M | — |
| 自由现金流率自由现金流/营收 | 9.1% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $1.0B | — |
8季度趋势，按日历期对齐
经营现金流OPENRPRX
| Q4 25 | $70.0M | $827.1M | ||
| Q3 25 | $435.0M | $702.6M | ||
| Q2 25 | $823.0M | $364.0M | ||
| Q1 25 | $-279.0M | $596.1M | ||
| Q4 24 | $-80.0M | $742.5M | ||
| Q3 24 | $62.0M | $703.6M | ||
| Q2 24 | $-399.0M | $658.2M | ||
| Q1 24 | $-178.0M | $664.6M |
自由现金流OPENRPRX
| Q4 25 | $67.0M | — | ||
| Q3 25 | $432.0M | — | ||
| Q2 25 | $821.0M | — | ||
| Q1 25 | $-283.0M | — | ||
| Q4 24 | $-83.0M | — | ||
| Q3 24 | $56.0M | — | ||
| Q2 24 | $-407.0M | — | ||
| Q1 24 | $-186.0M | — |
自由现金流率OPENRPRX
| Q4 25 | 9.1% | — | ||
| Q3 25 | 47.2% | — | ||
| Q2 25 | 52.4% | — | ||
| Q1 25 | -24.5% | — | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | -26.9% | — | ||
| Q1 24 | -15.7% | — |
资本支出强度OPENRPRX
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.7% | — |
现金转化率OPENRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPEN
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
